You are here: Industry Insights > Cytovance

News List

Cytovance Biologics Offers Licensing for Plasmid DNA Manufacturing contractpharma
March 10, 2021
The Keystone Expression System pDNA platform is an end-to-end solution for manufacturing GMP pDNA at scale.
Cytovance Expands Partnership with Nature Technology Corp. contractpharma
December 04, 2020
Now offers NTC’s proprietary HyperGRO manufacturing platform for plasmid DNA CGMP manufacturing.
Cytovance Appoints CEO contractpharma
November 13, 2020
Bin Zhang has been with Cytovance as a member of the Board of Directors since 2018.
Cytovance and Akshaya Enter Vaccine Collaboration contractpharma
April 26, 2020
Partnership to focus on therapeutics for treatment of coronavirus and hepatitis B virus infections.
Cytovance Promotes Jesse McCool to CEO contractpharma
April 06, 2020
Cytovance Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO), has appointed Dr. Jesse McCool to chief executive officer.
Cytovance Biologics Inc. Appoints Chief Technology Officer contractpharma
June 28, 2019
Dr. Jesse McCool, former VP of Microbial Services, will serve the company as CTO.
Cytovance Completes Second FDA PAI of Oklahoma Facilities contractpharma
June 20, 2019
Demonstrates capabilities and cGMP compliance in manufacturing commercial products.
Cytovance Completes FDA Inspection at Oklahoma City Facilities contractpharma
July 25, 2017
Cytovance Biologics has completed an FDA inspection that took place July 11, 2017 at its Oklahoma City facilities. The eight-day inspection focused on Quality Systems.